Results 211 to 220 of about 249,373 (343)
Efficacy of Impella Microaxial left ventricular assist device as bridge to transplant in children with end stage heart disease. [PDF]
Alsoufi B +5 more
europepmc +1 more source
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Atrial fibrillation in continuous flow-left ventricular assist device (CF-LVAD) patients: impact on pathophysiology. [PDF]
Nair N, Du D, Mahesh B.
europepmc +1 more source
Transapical miniaturized ventricular assist device: Design and initial testing [PDF]
Mark S. Slaughter +6 more
openalex +1 more source
Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes
F. Gustafsson, J. Rogers
semanticscholar +1 more source
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba +10 more
wiley +1 more source
Novel Applications of a Percutaneous Dual-Lumen Cannula Beyond a Right Ventricular Assist Device. [PDF]
Butler P +4 more
europepmc +1 more source
Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock [PDF]
Koji Takeda +9 more
openalex +1 more source

